Hikma Pharmaceuticals

A global generic and specialty medicines company, listed in London, that opened a UK commercial office in London in 2024 to supply NHS hospitals.

About Hikma Pharmaceuticals

Hikma makes and sells medicines, including injectable medicines used in hospitals, generic medicines and branded products. It operates in many countries and its employees number around 10,000.

Its stated aim is "putting better health within reach every day" by making high-quality medicines accessible. Its three pillars are Caring, Collaborating and Innovating.

Hikma PLC is listed on the London Stock Exchange. In June 2024 it announced a new UK commercial office in London, co-located with the Hikma PLC office, to supply injectable medicines to NHS hospitals directly. Those medicines are made at its sites in Portugal, Italy and Germany, not in the UK. We did not find UK manufacturing sites or a UK headcount.

Staff on its careers page describe a close, family-like feel and say people often move between functions. These are company-published views.

Its careers page invites people to "Launch your career with Hikma internships" and staff say some colleagues began as interns or temporary workers and moved into full-time roles. We did not find UK-specific internships, graduate schemes or apprenticeships, so UK entry routes need checking on its UK careers pages.

What they do

• {'desc': 'Hospital medicines, supplied to NHS hospitals in the UK.', 'title': 'Injectable medicines'}
• {'desc': 'Lower-cost versions of established medicines.', 'title': 'Generic medicines'}
• {'desc': 'Specialty branded products.', 'title': 'Branded medicines'}

Key facts

• Mission: "putting better health within reach every day"
• Three pillars: Caring, Collaborating, Innovating
• UK commercial office opened in London, June 2024
• Around 10,000 people worldwide (own page)

Website: www.hikma.com